Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer

References

• Wiebe E, Denny L, Thomas G. Cancer of the cervix uteri. Int J Gynaecol Obstet 2012;119(Suppl 2):S100-S9
   PubMed Web of Science ®Google Scholar
• Liu S, Semenciw R, Mao Y. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 2001;164:1151-2
   PubMed Web of Science ®Google Scholar
• Liu S, Semenciw R, Probert A, Mao Y. Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer 2001;11:24-31
   PubMed Web of Science ®Google Scholar
• Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 2001;357:1490-3
   PubMed Web of Science ®Google Scholar
• Krane JF, Granter SR, Trask CE, et al. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer 2001;93:8-15
   PubMed Web of Science ®Google Scholar
• Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 2010;116:140-6
   PubMed Web of Science ®Google Scholar
• van der Horst J, Siebers AG, Bulten J, et al. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004–2013. Cancer Med 2017;6:416-23
   PubMed Web of Science ®Google Scholar
• Lee JY, Kim YT, Kim S, et al. Prognosis of cervical cancer in the era of concurrent chemoradiation from national database in Korea: a comparison between squamous cell carcinoma and adenocarcinoma. PLoS One 2015;10:e0144887
   PubMed Web of Science ®Google Scholar
• Huang YT, Wang CC, Tsai CS, et al. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 2011;80:429-36
   PubMed Web of Science ®Google Scholar
• Intaraphet S, Kasatpibal N, Siriaunkgul S, et al. Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev 2013;14:5355-60
   PubMedGoogle Scholar
• Galic V, Herzog TJ, Lewin SN, et al. Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 2012;125:287-91
   PubMed Web of Science ®Google Scholar
• Yamauchi M, Fukuda T, Wada T, et al. Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I–II cervical cancer. Mol Clin Oncol 2014;2:518-24
   PubMedGoogle Scholar
• Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol 2012;125:292-6
   PubMed Web of Science ®Google Scholar
• Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76(10 Suppl):1948-55
   PubMed Web of Science ®Google Scholar
• Teke F, Yoney A, Teke M, et al. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Asian Pac J Cancer Prev 2014;15:2815-19
   PubMedGoogle Scholar
• Zolciak-Siwinska A, Piotrkowicz N, Jonska-Gmyrek J, et al. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study. Radiother Oncol 2013;109:194-9
   PubMed Web of Science ®Google Scholar
• Baalbergen A, Ewing-Graham PC, Hop WC, et al. Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;92:262-7
   PubMed Web of Science ®Google Scholar
• Takeshima N, Utsugi K, Hasumi K, Takizawa K. Postoperative adjuvant chemotherapy for node-positive cervical adenocarcinoma. Int J Gynecol Cancer 2009;19:277-80
   PubMed Web of Science ®Google Scholar
• Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53
   PubMed Web of Science ®Google Scholar
• Serkies K, Jassem J. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys 2004;60:814-21
   PubMed Web of Science ®Google Scholar
• Vale C, Tierney JF, Stewart LA, et al. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008;26:5802-12
   PubMed Web of Science ®Google Scholar
• Binbin T, Lingying W, Manni H, et al. Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy. Zhonghua Fu Chan Ke Za Zhi 2014;49:348-54
   PubMedGoogle Scholar
• Jung EJ, Byun JM, Kim YN, et al. Cervical adenocarcinoma has a poorer prognosis and a higher propensity for distant recurrence than squamous cell carcinoma. Int J Gynecol Cancer 2017;27:1228-36
   PubMed Web of Science ®Google Scholar
• Zhou J, Wu SG, Sun JY, et al. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis. J Cancer Res Clin Oncol 2017;143:115-22
   PubMed Web of Science ®Google Scholar
• Waldenström AC, Horvath G. Survival of patients with adenocarcinoma of the uterine cervix in western Sweden. Int J Gynecol Cancer 1999;9:18-23
   PubMed Web of Science ®Google Scholar
• Peters WA 3rd, Liu PY, Barrett RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000;18:1606-13
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Nakanishi T, Inoue T, Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 1999;73:42-6
   PubMed Web of Science ®Google Scholar
• Monk BJ, Tewari KS, Koh WJ. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 2007;25:2952-65
   PubMed Web of Science ®Google Scholar
• Nogueira-Rodrigues A, do Carmo CC, Viegas C, et al. Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer. Clin Cancer Res 2008;14:6324-9
   PubMed Web of Science ®Google Scholar
• Tang J, Tang Y, Yang J, Huang S. Chemoradiation and adjuvant chemotherapy in advanced cervical adenocarcinoma. Gynecol Oncol 2012;125:297-302
   PubMed Web of Science ®Google Scholar
• Tsubamoto H, Maeda H, Kanazawa R, et al. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma. Gynecol Oncol 2013;129:129-34
   PubMed Web of Science ®Google Scholar
• Yokoi E, Mabuchi S, Takahashi R, et al. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. J Gynecol Oncol 2017;28:e19
   PubMed Web of Science ®Google Scholar
• Jonska-Gmyrek J, Gmyrek L, Lindner B, et al. Prognostic value of histopathology in cervical cancer patients. Ginekol Pol 2010;81:668-73
   PubMed Web of Science ®Google Scholar
• Rose PG. Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm? Gynecol Oncol 2012;125:285-6
   PubMed Web of Science ®Google Scholar
• Wright AA, Howitt BE, Myers AP, et al. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. Cancer 2013;119:3776-83
   PubMed Web of Science ®Google Scholar
• Contag SA, Gostout BS, Clayton AC, et al. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;95:610-17
   PubMed Web of Science ®Google Scholar
• Hall JS, Leong HS, Armenoult LS, et al. Exon-array profiling unlocks clinically and biologically relevant gene signatures from formalin-fixed paraffin-embedded tumour samples. Br J Cancer 2011;104:971-81
   PubMed Web of Science ®Google Scholar
• Seamon LG, Java JJ, Monk BJ, et al. Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study. Br J Cancer 2018;118:162-70
   PubMed Web of Science ®Google Scholar
• Tornessello ML, Buonaguro L, Buonaguro FM. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review. Gynecol Oncol 2013;128:442-8
   PubMed Web of Science ®Google Scholar
• Lee EJ, McClelland M, Wang Y, et al. Distinct DNA methylation profiles between adenocarcinoma and squamous cell carcinoma of human uterine cervix. Oncol Res 2010;18:401-8
   PubMed Web of Science ®Google Scholar
• Schefter T, Winter K, Kwon JS, et al. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. Int J Radiat Oncol Biol Phys 2014;88:101-5
   PubMed Web of Science ®Google Scholar
• Salomon-Perzynska M, Perzynski A, Rembielak-Stawecka B, et al. VEGF-targeted therapy for the treatment of cervical cancer – literature review. Ginekol Pol 2014;85:461-5
   PubMed Web of Science ®Google Scholar
• Chen RJ, Lin YH, Chen CA, et al. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan. Gynecol Oncol 1999;73:184-90
   PubMed Web of Science ®Google Scholar
• Kilgore LC, Soong SJ, Gore H, et al. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988;31:137-53
   PubMed Web of Science ®Google Scholar
• Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991;77:912-17
   PubMed Web of Science ®Google Scholar
• Kleine W, Rau K, Schwoeorer D, Pfleiderer A. Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol 1989;35:145-9
   PubMed Web of Science ®Google Scholar